Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Dalrada Financial Establishes New Subsidiary

Dalrada Financial Corp.
Posted on: 09 Oct 18
Dalrada Financial Establishes New Subsidiary

PR Newswire

SAN DIEGO, Oct. 9, 2018

SAN DIEGO, Oct. 9, 2018 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO) is the majority owner of a new subsidiary, Dalrada Health Products Corp, to become the marketing arm of the corporation. Dalrada Health Products Corp will partner with client companies for the distribution of medical disposables, hospital equipment & furniture, medical devices, laboratory and dental products.

The Dalrada Health Products Corp is the second of new ventures that DFCO is creating. In June, the company announced Dalrada Precision, which will facilitate sales through previously established and new sales channels. Dalrada Precision will provide Management Services to other corporations by finding sourcing solutions.

Safe Harbor:
Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.


View original content:

SOURCE Dalrada Financial Corp.

PR Newswire

Last updated on: 09/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.